Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Cancer Causes & Control : CCC|September 20, 2001
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)H Eerola, E Pukkala, S Pyrhönen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric studyT Taube, I Elomaa, C Blomqvist, et al.
British Journal of Cancer|January 1, 1996
Type I and type III collagen metabolites in adult osteosarcoma patientsT Wiklund, C Blomqvist, L Risteli, et al.
Bone|January 1, 1987
Treatment of skeletal disease in breast cancer: a controlled clodronate trialI Elomaa, C Blomqvist, L Porkka, et al.
British Journal of Cancer|September 17, 2009
Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinomaV Koljonen, H Kukko, E Pukkala, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 28, 2008
Cost-utility of breast reduction surgery--a prospective studyE Tykkä, P Räsänen, E Tukiainen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 30, 2001
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancerJ Sjöström, H Alfthan, H Joensuu, et al.
British Journal of Cancer|May 1, 1995
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?P Hietanen, C Blomqvist, V M Wasenius, et al.
British Journal of Cancer|August 11, 2005
Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancerP Poikonen, J Sjöström, R-M Amini, et al.
Pageof 19